Author:
Fadel Fatina I.,Madani Hanan A,Kamel S M,Othman Shorouk A.,Salah Doaa M.
Abstract
Background: Cardiovascular disease (CVD) is the most common cause of mortality and morbidity in children with end stage kidney disease (ESKD) which arises from the interaction of several risk factors. The aim of the study is to assess CV risk of ESKD children and outline the impact of KTX on this CV risk. Also valuate the relation between plasma Netrin-1, chronic inflammatory markers and CV risk. Methods: Sixty ESKD (30 on regular hemodialysis (HD), 30 recipients of kidney transplant (KTX)) were assessed using 24 hour AMBP assessment, laboratory (including lipid profile and markers of chronic inflammation namely N/L and HsCRP) and echocardiographic data. Plasma netrin-1 was assessed by ELISA technique for all patients. Results: showed significant higher prevalence of hypertension, higher number of patients with 24hrs BP> 95th percentile by ABPM, more prevalence of nocturnal non-dipping BP, higher percentage of obese and overweight patients, worse biochemical analysis, higher chance of medical calcification by higher Po4 and Ca X Po4, higher triglyceride level and lower HDL level and higher N/L in HD than KTX group. Significant inverse relation was detected between plasma netrin 1 and Hs CRP and between netrin 1 and N/L (p<0.001).
Publisher
Universidad Tecnica de Manabi
Subject
Education,General Nursing
Reference94 articles.
1. Agarwal R. Blood pressure and mortality among hemodialysis patients. Hypertension 2010; 55: 762–768.
2. Ahbap E, Sakaci T, Kara E, Sahutoglu T, Koc Y, Basturk T & Unsal A. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clinical nephrology 2016; 85: 199-208.
3. Bandeali S and Farmer J. “High-density lipoprotein and atherosclerosis: The role of antioxidant activity,” Curr. Atheroscler. Rep 2012; 14: 101–107.
4. Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M,
5. de la Cruz JJ, Ruiz-Hurtado G, Segura J, Rodriguez-Artalejo F,